Cite

HARVARD Citation

    Urbonas, V. et al. (2018). Combination of cytokine-directed and anti-programmed cell death protein 1 therapy – a new attractive option in melanoma treatment?. Melanoma research. 28 (5), p. . [Online]. 
  
Back to record